GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1343.3534.55 (+2.64 %)

PREV CLOSE ( ) 1308.80

OPEN PRICE ( ) 1310.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 137257

TODAY'S LOW / HIGH ( )1272.40 1404.55

52 WK LOW / HIGH ( )1169.75 3596.7

NSE1338.5531.7 (+2.43 %)

PREV CLOSE( ) 1306.85

OPEN PRICE ( ) 1310.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1338.55 (1648)

VOLUME 2824623

TODAY'S LOW / HIGH( ) 1272.05 1404.60

52 WK LOW / HIGH ( )1167 3598

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978

Management Info

Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director

Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com/investor@glandpharma.com

Website www.glandpharma.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

27Jan Gland Pharma informs about analyst meet
Pursuant to Regulation 30 read with Part A of the Securities and Exchang..

27Jan USFDA conducts inspection at Gland Pha
The United States Food and Drug Administration (USFDA) has conducted an..

25Jan Gland Pharma shines despite reporting
Gland Pharma is currently trading at Rs. 1424.30, up by 67.30 points or..

24Jan Gland Pharma reports 15% fall in Q3 co
Gland Pharma has reported results for third quarter ended December 31, 2..

07Jan Gland Pharma’s arm inks share purchase
Gland Pharma's wholly owned subsidiary -- Gland Pharma International PTE..

Financials

in Millions

	QTR Dec 22	ANNUAL 22
Net Profit	2275.36	12121.55
Gross Profit	3052.4	16190.43
Operating Profit	3454.67	17345.79
Net Sales	9258.99	44007.08

EVENT CALENDAR

peer group

Abbott India (BSE) 21270.20 (1.49%)	M.Cap ( in Cr)45011.23
Alkem Laboratories (BSE) 3178.00 (3.67%)	M.Cap ( in Cr)38039.60
Astrazeneca Pharma I (BSE) 3333.00 (2.90%)	M.Cap ( in Cr)8315.13
Divi's Lab (BSE) 2800.35 (1.86%)	M.Cap ( in Cr)74340.49
Dr. Reddy's Lab (BSE) 4486.30 (1.00%)	M.Cap ( in Cr)74685.85

	PROMOTERS	57.86%
	FI/BANKS/INSURANCE	2.59%
	MUTUAL FUNDS/UTI	19.49%
	NON-INSTITUTION	14.34%
	FII	0.01%
	GOVERNMENT	0%

Scheme Name	Hold(%)
ICICI Pru Retiremen...	3.11
SBI Healthcare Opp ...	2.85
ICICI Pru Pharma He...	2.60
ICICI Pru India Opp...	2.38
Mirae Asset Healthc...	2.34
ICICI Pru MNC Fund(G)	2.30

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 1343.35. Its current market capitalisation stands at Rs 22123.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 44007.08 Cr and Total Income of Rs.46246.48 Cr. The company's management includes Allen Zhang, Yao Fang, Qiyu Chen, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Udo Jahannes Vetter, Naina Lal Kidwai, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote